glp-1 drugs and anesthesia ASA Advises No Longer Holding Agents Prior to Surgery for Most Patients Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists:
Description
Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

Steven Camp.
You may have been reading a lot about newly launched obesity drugs and I covered some of this in my podcast last year with Stephan Guyenet in anticipation

Learn how they differ from prescription medications, review the clinical evidence, understand safety considerations, and explore NHS-approved weight management treatments backed by NICE guidance.

Real-world Repatha (evolocumab) reviews from patients on Reddit, Drugs.com, and forums, compared against FOURIER trial data
